Journal article 1814 views 195 downloads
Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551
T. Min,
L. Wali,
D.M. Williams,
E. Plummer,
A. Gurung,
J.W. Stephens,
Jeffrey Stephens 
Current Medical Research and Opinion, Pages: 1 - 2
Swansea University Author:
Jeffrey Stephens
DOI (Published version): 10.1080/03007995.2017.1336432
Abstract
Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551
| Published in: | Current Medical Research and Opinion |
|---|---|
| ISSN: | 0300-7995 1473-4877 |
| Published: |
2017
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa34694 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Start Page: |
1 |
| End Page: |
2 |